Brilique 90 mg orodispersible tablets clinical trials

Evaluation of safety and efficacy of two ticagrelorbased de-escalation antiplatelet strategies in acute coronary syndrome: the randomized, multicenter, double-blind ELECTRA RCT study.

This study looks at safer ways to give blood-thinning medicines like Brilique and Aspirin after a heart attack. It compares different doses of ticagrelor to see which causes less serious bleeding while still preventing new heart problems.